Pegbio Co Ltd (2565)

Currency in HKD
52.05
-0.55(-1.05%)
Closed·
2565 Scorecard
Full Analysis
Stock generally trades with high price volatility
2565 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
51.4053.10
52 wk Range
8.6857.70
Key Statistics
Bid/Ask
51.90 / 52.20
Prev. Close
52.6
Open
52.9
Day's Range
51.4-53.1
52 wk Range
8.68-57.7
Volume
124.5K
Average Volume (3m)
465.66K
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2565 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Pegbio Co Ltd Company Profile

PegBio Co., Ltd., a biopharmaceutical company, focuses on the research and development of medicines for chronic diseases in China. The company’s products include PB-119, a glucagon like peptide 1 receptor agonist for the treatment of type 2 diabetes mellitus and obesity. The company’s PB-718 that is in b/IIa clinical trials for the treatment non-alcoholic steatohepatitis (NASH) (PB-718 for obesity and NASH); and PB-1902 that is in phase II clinical trials for the treatment of opioids constipation and obesity. It is also developing GLP-1 for the first-line treatment of type 2 diabetes mellitus and obesity; and PB-722 that has completed the FDA orphan drug qualification certification for use in the treatment of congenital hyperinsulinemia. Additionally, it is also conducting preclinical studies test on PB-2301, a GLP-1/glucose-dependent insulinotropic polypeptide and PB-2309, a GLP-1/GIP/ glucagon triple receptor agonist for the treatment of type 2 diabetes mellitus, NASH, and obesity. The company was incorporated in 2008 and is based in Hangzhou, China.

Employees
58
Market
Hong Kong

Compare 2565 to Peers and Sector

Metrics to compare
2565
Peers
Sector
Relationship
P/E Ratio
−60.8x−37.5x−0.7x
PEG Ratio
-−0.460.00
Price/Book
52.8x6.4x2.6x
Price / LTM Sales
-20.2x3.4x
Upside (Analyst Target)
-38.4%37.6%
Fair Value Upside
Unlock−14.2%5.3%Unlock

Earnings

Latest Release
Aug 26, 2025
EPS / Forecast
-0.25 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

2565 Income Statement

People Also Watch

27.48
1044
-0.22%
10.40
0960
-2.16%
18.42
1099
-1.18%
5.80
1368
-3.49%

FAQ

What Stock Exchange Does Pegbio Trade On?

Pegbio is listed and trades on the Hong Kong Stock Exchange stock exchange.

What Is the Stock Symbol for Pegbio?

The stock symbol for Pegbio is "2565."

What Is the Pegbio Market Cap?

As of today, Pegbio market cap is 14.68B.

What Is Pegbio's Earnings Per Share (TTM)?

The Pegbio EPS (TTM) is -0.60.

From a Technical Analysis Perspective, Is 2565 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Pegbio Stock Split?

Pegbio has split 0 times.

How Many Employees Does Pegbio Have?

Pegbio has 58 employees.

What is the current trading status of Pegbio (2565)?

As of 17 Oct 2025, Pegbio (2565) is trading at a price of 52.05, with a previous close of 52.60. The stock has fluctuated within a day range of 51.40 to 53.10, while its 52-week range spans from 8.68 to 57.70.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.